Oncotelic's Nanoparticle Breakthrough Targets Cancer Treatment Limitations
January 9, 2026 — Oncotelic Therapeutics advances nanoparticle cancer treatment with Sapu-003, enhancing drug delivery through innovative nanotechnology that improves bioavailability and tumor targeting for better patient outcomes.